- Home
- PINE vs SLDB Comparison
PINE vs SLDB Comparison
Compare PINE & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINE
- SLDB
- Stock Information
- Founded
- PINE 2019
- SLDB 2013
- Country
- PINE United States
- SLDB United States
- Employees
- PINE N/A
- SLDB N/A
- Industry
- PINE Real Estate Investment Trusts
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PINE Real Estate
- SLDB Health Care
- Exchange
- PINE Nasdaq
- SLDB Nasdaq
- Market Cap
- PINE 220.4M
- SLDB 234.8M
- IPO Year
- PINE 2019
- SLDB 2018
- Fundamental
- Price
- PINE $14.58
- SLDB $5.28
- Analyst Decision
- PINE Strong Buy
- SLDB Strong Buy
- Analyst Count
- PINE 8
- SLDB 10
- Target Price
- PINE $19.00
- SLDB $15.10
- AVG Volume (30 Days)
- PINE 80.6K
- SLDB 1.7M
- Earning Date
- PINE 07-24-2025
- SLDB 08-12-2025
- Dividend Yield
- PINE 7.85%
- SLDB N/A
- EPS Growth
- PINE N/A
- SLDB N/A
- EPS
- PINE 0.07
- SLDB N/A
- Revenue
- PINE $53,967,000.00
- SLDB N/A
- Revenue This Year
- PINE $8.54
- SLDB N/A
- Revenue Next Year
- PINE $3.03
- SLDB N/A
- P/E Ratio
- PINE $195.28
- SLDB N/A
- Revenue Growth
- PINE 14.94
- SLDB N/A
- 52 Week Low
- PINE $14.41
- SLDB $2.41
- 52 Week High
- PINE $19.42
- SLDB $10.37
- Technical
- Relative Strength Index (RSI)
- PINE 40.64
- SLDB 65.14
- Support Level
- PINE $14.42
- SLDB $4.76
- Resistance Level
- PINE $14.89
- SLDB $5.70
- Average True Range (ATR)
- PINE 0.27
- SLDB 0.38
- MACD
- PINE -0.02
- SLDB 0.02
- Stochastic Oscillator
- PINE 18.68
- SLDB 78.63
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.